Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
137.5 USD | +1.54% | -2.61% | +3.83% |
05-31 | Neurocrine Biosciences Insider Sold Shares Worth $5,338,565, According to a Recent SEC Filing | MT |
05-28 | Neurocrine Biosciences Says CEO Kevin Gorman Retiring | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.83% | 13.63B | |
+13.92% | 118B | |
+12.42% | 106B | |
-4.18% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.19% | 15.56B | |
+27.24% | 12.27B | |
+81.64% | 8.87B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Insider Sold Shares Worth $297,860, According to a Recent SEC Filing